Skip to main content
Clinical Trials/JPRN-UMIN000048933
JPRN-UMIN000048933
Completed
未知

Survey on Lung Cancer Patients' Experience and Awareness of Precision Medicine - Survey on Lung Cancer Patients' Experience and Awareness of Precision Medicine

Medical Affairs, Japan Oncology Business Uni, Takeda Pharmaceutical Company Limited.0 sites200 target enrollmentSeptember 26, 2022
Conditionsung Cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
ung Cancer
Sponsor
Medical Affairs, Japan Oncology Business Uni, Takeda Pharmaceutical Company Limited.
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2022
End Date
October 31, 2022
Last Updated
2 years ago
Study Type
Others,meta-analysis etc
Sex
All

Investigators

Sponsor
Medical Affairs, Japan Oncology Business Uni, Takeda Pharmaceutical Company Limited.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Unable to complete questionnaires 2\.Provide inadequate response (Outliers of quantity data, inconsistent responses, unmotivated responses, etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials